← Eichor
Condition: Antiplatelet Drugs Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antiplatelet Drugs

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome
Phase 4 · 1 location(s) · Shanghai Zhongshan Hospital · NCT06451198Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?
Phase N/A · 12 location(s) · Rennes University Hospital · NCT03687528Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic
NA · 1 location(s) · Rajaie Cardiovascular Medical and Research Center · NCT06541691Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
Phase 1 · 1 location(s) · Montreal Heart Institute · NCT05702463AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
Phase 4 · 2 location(s) · University Hospital, Bordeaux · NCT04796714Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy
NA · 1 location(s) · Centre intégré universitaire de santé et de services sociaux · NCT07089030Characterization of Exosomes Platelets-released
Phase N/A · 1 location(s) · Centro Cardiologico Monzino · NCT06298682Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs
EARLY_Phase 1 · 1 location(s) · University of Michigan · NCT06933056Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions
NA · 3 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05732701PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
Phase 4 · 1 location(s) · Kindai University · NCT05709626Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding R
NA · 18 location(s) · Samsung Medical Center · NCT06742931STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for O
Phase 4 · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT06901466Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
NA · 2 location(s) · Massachusetts General Hospital · NCT07613840Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients
NA · 1 location(s) · Yonsei University · NCT05936606DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial
NA · 1 location(s) · Yonsei University · NCT05305482STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
NA · 2 location(s) · IGLESIAS Juan Fernando · NCT05785897Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation
Phase 4 · 1 location(s) · Kyoto University · NCT06723145Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents
Phase N/A · 2 location(s) · Jordan Collaborating Cardiology Group · NCT07039149Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percu
Phase 4 · 3 location(s) · Odense University Hospital · NCT06718179Transmission Electron Microscopy Images for Platelet Ultrastructural Criteria Before and After the Onset of an Antiplate
NA · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT05004233Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
Phase 4 · 1 location(s) · University of Florida · NCT06228456Healthcare Services for Older People Who Have Fallen With Potential Head Injury
Phase N/A · 1 location(s) · Portsmouth Hospitals NHS Trust · NCT07111871Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREED
NA · 14 location(s) · Gan Lijun · NCT07587099Future Optimal Research and Care Evaluation
Phase N/A · 4 location(s) · J.M. ten Berg · NCT03823547Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent
Phase 4 · 33 location(s) · Asan Medical Center · NCT05418556The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an
NA · 19 location(s) · National University of Ireland, Galway, Ireland · NCT04923191Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO
NA · 1 location(s) · Fondazione Ricerca e Innovazione Cardiovascolare ETS · NCT0653556824 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A
NA · 1 location(s) · China National Center for Cardiovascular Diseases · NCT06014060Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs
NA · 1 location(s) · IGLESIAS Juan Fernando · NCT05650411Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions
Phase N/A · 2 location(s) · Centre Hospitalier Universitaire Dijon · NCT03773159
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.